Eugenio Cersosimo

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Combination Therapy

Left Ventricular

Vascular Smooth Muscle Cells

Glycemic Control

Top Venues

Diabetes, obesity & metabolism

Endocrinology, diabetes & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Xi Chen, Devjit Tripathy, Robert Chilton, Andrea Hansis-Diarte, Marzieh Salehi, Carolina Solis-Herrera, Eugenio Cersosimo, Ralph A De Fronzo
Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects. Diabetes 73 (6) (2024)
Xi Chen, Devjit Tripathy, Robert Chilton, Andrea Hansis-Diarte, Marzieh Salehi, Carolina Solis-Herrera, Eugenio Cersosimo, Ralph A De Fronzo
Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects. Diabetes 73 (6) (2024)
Xi Chen, Devjit Tripathy, Robert Chilton, Andrea Hansis-Diarte, Marzieh Salehi, Carolina Solis-Herrera, Eugenio Cersosimo, Ralph A De Fronzo
Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects. Diabetes 73 (6) (2024)
Xi Chen, Devjit Tripathy, Robert Chilton, Andrea Hansis-Diarte, Marzieh Salehi, Carolina Solis-Herrera, Eugenio Cersosimo, Ralph A De Fronzo
Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects. Diabetes 73 (6) (2024)
Eugenio Cersosimo, Mariam Alatrach, Carolina Solis-Herrera, Baskoy Gozde, John Adams, Andrea Hansis-Diarte, Amalia Gastaldelli, Alberto Chavez, Curtis Triplitt, Ralph A DeFronzo
Emergence of a New Gluco-Regulatory Mechanism for Glycemic Control with Dapagliflozin/Exenatide Therapy in Type 2 Diabetes. The Journal of clinical endocrinology and metabolism (2023)
Mariam Alatrach, Christina Agyin, Carolina Solis-Herrera, Olga Lavryneko, John Adams, Amalia Gastaldelli, Curtis Triplitt, Ralph A De Fronzo, Eugenio Cersosimo
Dapagliflozin Impairs the Suppression of Endogenous Glucose Production in Type 2 Diabetes Following Oral Glucose. Diabetes care 45 (6) (2022)
Olga Lavynenko, Muhammad A Abdul-Ghani, Mariam Alatrach, Curtiss Puckett, John Adams, Siham Abdelgani, Naim Alkhouri, Curtis Triplitt, Geoffrey D Clarke, Juan A Vasquez, Jinqi Li, Eugenio Cersosimo, Francesco Rubino, Muhammad Abdul-Ghani
Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT). Diabetes, obesity & metabolism 24 (5) (2022)
Alexander J Moody, Marjorie Molina-Wilkins, Geoffrey D Clarke, Aurora Merovci, Carolina Solis-Herrera, Eugenio Cersosimo, Robert J Chilton, Patricia Iozzo, Francesco Rubino, Muhammad A Abdul-Ghani, Muhammad Abdul-Ghani
Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes. Diabetes, obesity & metabolism (2022)
Carolina Solis-Herrera, Eugenio Cersosimo, Curtis Triplitt
Antihyperglycemic Algorithms for Type 2 Diabetes: Focus on Nonglycemic Outcomes. Diabetes spectrum : a publication of the American Diabetes Association 34 (3) (2021)
Yuejuan Qin, John Adams, Carolina Solis-Herrera, Curtis Triplitt, Ralph A De Fronzo, Eugenio Cersosimo
Clinical Parameters, Fuel Oxidation, and Glucose Kinetics in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin. Diabetes care 43 (10) (2020)
Eugenio Cersosimo, Xiaojing Xu, Tomoko Terasawa, Lily Q Dong
Anti-inflammatory and anti-proliferative action of adiponectin mediated by insulin signaling cascade in human vascular smooth muscle cells. Molecular biology reports 47 (9) (2020)
Muhammad A Abdul-Ghani, Curtiss Puckett, John Adams, Ahmad Khattab, Gozde Baskoy, Eugenio Cersosimo, Curtis Triplitt, Ralph A De Fronzo
Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT. Diabetes care 44 (2) (2020)
Mariam Alatrach, Christina Agyin, John Adams, Robert J Chilton, Curtis Triplitt, Muhammad Abdul-Ghani, Eugenio Cersosimo
Glucose lowering and vascular protective effects of cycloset added to GLP-1 receptor agonists in patients with type 2 diabetes. Endocrinology, diabetes & metabolism 1 (4) (2018)
Robert Martinez, Hussein Al-Jobori, Ali M Ali, John Adams, Muhammad Abdul-Ghani, Curtis Triplitt, Ralph A De Fronzo, Eugenio Cersosimo
Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy. Diabetes 67 (6) (2018)
Geoffrey D Clarke, Marjorie Molina-Wilkins, Carolina Solis-Herrera, Verna Mendez, Adriana Monroy, Eugenio Cersosimo, Robert J Chilton, Muhammad A Abdul-Ghani, Muhammad Abdul-Ghani
Impaired left ventricular diastolic function in T2DM patients is closely related to glycemic control. Endocrinology, diabetes & metabolism 1 (2) (2018)
Eugenio Cersosimo, Eric L Johnson, Christina Chovanes, Neil Skolnik
Initiating therapy in patients newly diagnosed with type 2 diabetes: Combination therapy vs a stepwise approach. Diabetes, obesity & metabolism 20 (3) (2017)